High-density lipoprotein inhibits the uptake of modified low- density lipoprotein and the expression of CD36 and FcγRI

Journal of Atherosclerosis and Thrombosis

Volumn 17, Issue 8, 2010, Pages 844-857

  Carvalho, Márcia Dias Teixeira ^a   Vendrame, Célia Maria Vieira ^a   Ketelhuth, Daniel Francisco Jacon ^a   Yamashiro Kanashiro, Edite Hatsumi ^a   Goto, Hiro ^a   Gidlund, Magnus ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Atherosclerosis; Foam cells; Lipids; Lipoproteins; Macrophages

Indexed keywords

CD36 ANTIGEN; CD64 ANTIGEN; FLUORESCEIN ISOTHIOCYANATE; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; OXIDIZED LOW DENSITY LIPOPROTEIN;

ANION EXCHANGE CHROMATOGRAPHY; ARTICLE; ATHEROGENESIS; CELL DIFFERENTIATION; FLOW CYTOMETRY; GEL PERMEATION CHROMATOGRAPHY; IN VITRO STUDY; MONOCYTE; PROTEIN EXPRESSION; RECEPTOR DOWN REGULATION;

EID: 77957694793     PISSN: 13403478     EISSN: 18803873     Source Type: Journal    
DOI: 10.5551/jat.3905     Document Type: Article

References (53)

1. Hansson GK, Libby P: The immune response in atherosclerosis: a double-edged sword. Nat Rev Immunol, 2006; 6: 508-519
2. Hansson GK, Robertson AK, Soderberg-Naucler C: Inflammation and atherosclerosis. Annu Rev Pathol, 2006; 1: 297-329
3. Steinbrecher UP, Parthasarathy S, Leake DS, Witztum JL, Steinberg D: Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids. Proc Natl Acad Sci U S A, 1984; 81: 3883-3887
4. Frostegard J, Nilsson J, Haegerstrand A, Hamsten A, Wigzell H, Gidlund M: Oxidized low density lipoprotein induces differentiation and adhesion of human monocytes and the monocytic cell line U937. Proc Natl Acad Sci U S A, 1990; 87: 904-908
5. Mertens A, Holvoet P: Oxidized LDL and HDL: antagonists in atherothrombosis. Faseb J, 2001; 15: 2073-2084
6. Assmann G, Nofer JR: Atheroprotective effects of high-density lipoproteins. Annu Rev Med, 2003; 54: 321-341
7. Fernandes JL, Orford JL, Garcia C, Coelho OR, Gidlund M, Blotta MH: Differences in human antioxidized LDL autoantibodies in patients with stable and unstable angina. J Autoimmun, 2004; 23: 345-352
8. Ketelhuth DF, Tonini GC, Carvalho MD, Ramos RF, Boschcov P, Gidlund M: Autoantibody response to chromatographic fractions from oxidized LDL in unstable angina patients and healthy controls. Scand J Immunol, 2008; 68: 456-462
9. Quintao EC: Is reverse cholesterol transport a misnomer for suggesting its role in the prevention of atheroma formation? Atherosclerosis, 1995; 116: 1-14
10. Ross R: Atherosclerosis--an inflammatory disease. N Engl J Med, 1999; 340: 115-126
11. Steinbrecher UP: Receptors for oxidized low density lipoprotein. Biochim Biophys Acta, 1999; 1436: 279-298
12. Rader DJ, Pure E: Lipoproteins, macrophage function, and atherosclerosis: beyond the foam cell? Cell Metab, 2005; 1: 223-230
13. Rios FJ, Jancar S, Melo IB, Ketelhuth DF, Gidlund M: Role of PPAR-gamma in the modulation of CD36 and FcgammaRII induced by LDL with low and high degrees of oxidation during the differentiation of the monocytic THP-1 cell line. Cell Physiol Biochem, 2008; 22: 549-556
14. Carvalho MD, Harada LM, Gidlund M, Ketelhuth DF, Boschcov P, Quintao EC: Macrophages take up triacylglycerol-rich emulsions at a faster rate upon co-incubation with native and modified LDL: An investigation on the role of natural chylomicrons in atherosclerosis. J Cell Biochem, 2002; 84: 309-323
15. Jones NL, Reagan JW, Willingham MC: The pathogenesis of foam cell formation: modified LDL stimulates uptake of co-incubated LDL via macropinocytosis. Arterioscler Thromb Vasc Biol, 2000; 20: 773-781
16. Oliveira RT, Mamoni RL, Souza JR, Fernandes JL, Rios FJ, Gidlund M, Coelho OR, Blotta MH: Differential expression of cytokines, chemokines and chemokine receptors in patients with coronary artery disease. Int J Cardiol, 2008; 136: 17-26
17. Sugano R, Yamamura T, Harada-Shiba M, Miyake Y, Yamamoto A: Uptake of oxidized low-density lipoprotein in a THP-1 cell line lacking scavenger receptor A. Atherosclerosis, 2001; 158: 351-357
18. Tertov VV, Kaplun VV, Orekhov AN: Lack of correlation between degree of human plasma low density lipoprotein oxidation and its atherogenic potential. Biofactors, 1997; 6: 139-143
19. Kapinsky M, Torzewski M, Buchler C, Duong CQ, Rothe G, Schmitz G: Enzymatically degraded LDL preferentially binds to CD14(high) CD16(+) monocytes and induces foam cell formation mediated only in part by the class B scavenger-receptor CD36. Arterioscler Thromb Vasc Biol, 2001; 21: 1004-1010
20. Klouche M, Rose-John S, Schmiedt W, Bhakdi S: Enzymatically degraded, nonoxidized LDL induces human vascular smooth muscle cell activation, foam cell transformation, and proliferation. Circulation, 2000; 101: 1799-1805
21. Carvalho MD, Tobias VE, Vendrame CM, Shimabukuro AF, Gidlund M, Quintao EC: Lipoproteins modify the macrophage uptake of triacylglycerol emulsion and of zymosan particles by similar mechanisms. Lipids, 2000; 35: 55-59
22. Carvalho MD, Tobias VE, Vendrame CM, Shimabukuro AF, Gidlund M, Quintao EC: Zymosan phagocytosis by mouse peritoneal macrophages is increased by apoHDL-and not by intact HDL-covered particles. Braz J Med Biol Res, 2000; 33: 313-316
23. Bigler RD, Brown HM, Guyre PM, Lund-Katz S, Scerbo L, Esfahani M: Effect of low-density lipoprotein on the expression of high affinity Fc gamma receptors. Biochim Biophys Acta, 1989; 1011: 102-109
24. Yang CY, Chen SH, Gianturco SH, Bradley WA, Sparrow JT, Tanimura M, Li WH, Sparrow DA, DeLoof H, Rosseneu M, Lee FS, Gu ZW, Gotto AM, Chan L: Sequence, structure, receptor-binding domains and internal repeats of human apolipoprotein B-100. Nature, 1986; 323: 738-742
25. Auwerx J: The human leukemia cell line, THP-1: a multifaceted model for the study of monocyte-macrophage differentiation. Experientia, 1991; 47: 22-31
26. Haller O, Gidlund M, Hellstrom U, Hammarstrom S, Wigzell H: A new surface marker on mouse natural killer cells: receptors for Helix pomatia A hemagglutinin. Eur J Immunol, 1978; 8: 765-771
27. Havel RJ, Eder HA, Bragdon JH: The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest, 1955; 34: 1345-1353
28. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ: Protein measurement with the Folin phenol reagent. J Biol Chem, 1951; 193: 265-275
29. Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature, 1970; 227: 680-685
30. Fremont L, Belguendouz L, Delpal S: Antioxidant activity of resveratrol and alcohol-free wine polyphenols related to LDL oxidation and polyunsaturated fatty acids. Life Sci, 1999; 64: 2511-2521
31. Sakai H, Kaneshige H, Endoh M: Determination of LDL receptors on cultured lymphocytes using fluorescein-labeled LDL. Am J Clin Pathol, 1982; 78: 58-62
32. Puhl H, Waeg G, Esterbauer H: Methods to determine oxidation of low-density lipoproteins. Methods Enzymol, 1994; 233: 425-441
33. Ozsoy MB, Pabuccuoglu A: The effect of acetaminophen on oxidative modification of low-density lipoproteins in hypercholesterolemic rabbits. J Clin Biochem Nutr, 2007; 41: 27-31
34. Khoo JC, Miller E, McLoughlin P, Steinberg D: Enhanced macrophage uptake of low density lipoprotein after self-aggregation. Arteriosclerosis, 1988; 8: 348-358
35. Gidlund M, Orn A, Pattengale PK, Jansson M, Wigzell H, Nilsson K: Natural killer cells kill tumour cells at a given stage of differentiation. Nature, 1981; 292: 848-850
36. Tsuchiya S, Yamabe M, Yamaguchi Y, Kobayashi Y, Konno T, Tada K: Establishment and characterization of a human acute monocytic leukemia cell line (THP-1). Int J Cancer, 1980; 26: 171-176
37. Vedie B, Myara I, Pech MA, Maziere JC, Maziere C, Caprani A, Moatti N: Fractionation of charge-modified low density lipoproteins by fast protein liquid chromatography. J Lipid Res, 1991; 32: 1359-1369
38. Gekle M, Mildenberger S, Freudinger R, Silbernagl S: Long-term protein exposure reduces albumin binding and uptake in proximal tubule-derived opossum kidney cells. J Am Soc Nephrol, 1998; 9: 960-968
39. Fletcher RH, Fletcher SW, Wagner EH: Clinical Epidemiology: the essential. Baltimore: Lippincott Williams & Wilkins; 1996
40. Anderson CL, Looney RJ, Culp DJ, Ryan DH, Fleit HB, Utell MJ, Frampton MW, Manganiello PD, Guyre PM: Alveolar and peritoneal macrophages bear three distinct classes of Fc receptors for IgG. J Immunol, 1990; 145: 196-201
41. Silverstein RL, Febbraio M: CD36 and atherosclerosis. Curr Opin Lipidol, 2000; 11: 483-491
42. Lusis AJ: Atherosclerosis. Nature, 2000; 407: 233-241
43. Han J, Hajjar DP, Zhou X, Gotto AM Jr, Nicholson AC: Regulation of peroxisome proliferator-activated receptorgamma- mediated gene expression. A new mechanism of action for high density lipoprotein. J Biol Chem, 2002; 277: 23582-23586
44. Meyer DF, Mayans MO, Groot PH, Suckling KE, Bruckdorfer KR, Perkins SJ: Time-course studies by neutron solution scattering and biochemical assays of the aggregation of human low-density lipoprotein during Cu(2+)- induced oxidation. Biochem J, 1995; 310 (Pt 2): 417-426
45. Steinbrecher UP, Witztum JL, Parthasarathy S, Steinberg D: Decrease in reactive amino groups during oxidation or endothelial cell modification of LDL. Correlation with changes in receptor-mediated catabolism. Arteriosclerosis, 1987; 7: 135-143
46. Ruiu G, Pinach S, Veglia F, Gambino R, Marena S, Uberti B, Alemanno N, Burt D, Pagano G, Cassader M: Phytosterol-Enriched Yogurt Increases LDL Affinity and Reduces CD36 Expression in Polygenic Hypercholesterolemia. Lipids, 2009; 44: 153-160
47. Collot-Teixeira S, Barbatis C, Bultelle F, Koutouzis M, Pasterkamp G, Fraser P, Kyriakides ZS, Poston RN, Ristagno A, McGregor L, Boulanger CM, Leseche G, McGregor JL: CD36 is significantly correlated with adipophilin in human carotid lesions and inversely correlated with plasma ApoAI. J Biomed Biotechnol, 2008; 2008: 813236
48. Oksjoki R, Kovanen PT, Lindstedt KA, Jansson B, Pentikainen MO: OxLDL-IgG immune complexes induce survival of human monocytes. Arterioscler Thromb Vasc Biol, 2006; 26: 576-583
49. Cazita PM, Berti JA, Aoki C, Gidlund M, Harada LM, Nunes VS, Quintao EC, Oliveira HC: Cholesteryl ester transfer protein expression attenuates atherosclerosis in ovariectomized mice. J Lipid Res, 2003; 44: 33-40
50. Fernvik EC, Ketelhuth DF, Russo M, Gidlund M: The autoantibody repertoire against copper- or macrophage-modified LDL differs in normolipidemics and hypercho-lesterolemic patients. J Clin Immunol, 2004; 24: 170-176
51. Ronchini KR, Duarte AJ, Casseb JS, Gidlund M: Cardiovascular complications and increased levels of circulating modified low density lipoprotein in HIV patients and patients with lipodystrophy. Braz J Med Biol Res, 2004; 37: 119-122
52. Calverley DC, Varteresian T, Brass E, Tsao-Wei DD, Groshen S, Mack WJ, Buchanan TA, Hodis HN, Schreiber AD: Association between monocyte Fcgamma subclass expression and acute coronary syndrome. Immun Ageing, 2004; 1: 4
53. Choi JS, Bae JY, Kim DS, Li J, Kim JL, Lee YJ, Kang YH: Dietary compound quercitrin dampens VEGF induction and PPARgamma activation in oxidized LDL-exposed murine macrophages: Association with Scavenger Receptor CD36. J Agric Food Chem, 2010; 58: 1333-1341